Growth Factors in Breast Cancer
Author Information
Author(s): C.-F. Qil, D.S. Liscia, N. Normanno, G. Merlo, G.R. Johnson, W.J. Gullick, F. Ciardiello, T. Saeki, R. Brandt, N. Kim, N. Kenney, D.S. Salomon
Primary Institution: National Cancer Institute
Hypothesis
The study investigates the expression of EGF-related peptides in human breast carcinomas and their potential as tumor markers.
Conclusion
Breast carcinomas express multiple EGF-related peptides, with differential expression of CR-1 potentially serving as a tumor marker.
Supporting Evidence
- 79% of breast carcinomas expressed TGF-a.
- 77% of breast carcinomas expressed amphiregulin.
- 82% of breast carcinomas expressed cripto-1.
- Significant inverse correlation between AR expression and p53 mutations.
- 66% of breast carcinomas co-expressed TGF-a, AR, and CR-1.
Takeaway
The study looked at how certain proteins related to growth in breast cancer are found in tumor cells, which could help doctors understand and treat the disease better.
Methodology
Immunocytochemistry was used to examine the expression of TGF-a, AR, and CR-1 in breast carcinoma and adjacent non-involved tissues.
Limitations
The study is limited by its small sample size and the lack of long-term follow-up data on patient outcomes.
Participant Demographics
The study included 68 primary infiltrating ductal and lobular breast carcinomas and 23 adjacent non-involved breast tissue samples.
Statistical Information
P-Value
0.008
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website